Tag: Phase 3 Clinical Trial

September 24, 2019

The Unspoken Potential of Rosacea Treatments

Treatments for rosacea largely remain limited, but the market is growing in size. Here's what you need to know about...
September 24, 2019

Ocular Therapeutix Doses First Patient in Phase 3 Clinical Trial

The Phase 3 trial of its drug DEXTENZA is to treat symptoms of allergic conjunctivitis, which is inflammation of the...
September 24, 2019

UroGen Reports Data From Two Studies

The company reported updated findings from its UGN-101 Phase 3 OLYMPUS Trial and initial data from its UGN-102 Phase 2b...
September 23, 2019

Abeona to Submit More Data to FDA Before Starting Phase 3 Trial

Following the announcement, shares of Abeona Therapeutics tumbled nearly 12 percent in Monday's trading session.
September 22, 2019

5 Top Weekly NASDAQ Biotech and Pharma Stocks: Lexicon Soars

Which biotech and pharma stocks were on the rise last week? We list the top gainers and what may have...
September 12, 2019

Ovid Therapeutics’ First Patient Randomized in Pivotal Phase 3 NEPTUNE Trial

Ovid Therapeutics (NASDAQ:OVID) has announced it has randomized the first patient in its Phase 3 NEPTUNE clinical trial of OV101...
September 10, 2019

Mesoblast and Grunenthal Partner on Lower Back Pain Cell Therapy

Under the terms of the agreement, Grunenthal will have exclusive rights to commercialize the treatment in Europe and Latin America.